Page results
-
Patient information for patients suffering from long COVID who are returning to work.
-
The Cancer Clinical Trials Unit (CCTU) supports clinical trials across all areas of cancer treatment at UCLH
-
This patient information is intended to help patients suffering form long COVID to manage and understand their headaches.
-
Our colorectal service fast-tracks investigations for the management of all suspected colorectal cancer. It also provides specialist surgical treatment for some patients within the North Central London sector who are diagnosed with bowel cancer under the NHS bowel cancer screening programme based at UCLH.
-
Thyroid cancer is a type of cancer that affects the thyroid gland, a small gland at the base of the neck.
-
The clinic at UCH is the world’s first to provide a multi-disciplinary service for adolescents and adults born with diverse sex development.
-
At UCLH we recognise how cancer and its treatment can affect the lives of patients and those close to them. We provide support, information and advice.
-
The Intestinal Failure (IF) Service at UCH is a multidisciplinary service managing the complex needs of patients with gastrointestinal fistulas. The team includes consultant surgeons, anaesthetists, radiologists and nutritional gastroenterologists, as well as specialist nurses with expertise in this area. At UCH we aim to assess patients referred to us quickly and plan every aspect of their care effectively.
-
This information has been written for patients who are having radiotherapy treatment to the brain and spine.
-
Nasopharyngeal cancer is a rare type of cancer that affects the part of the throat connecting the back of the nose to the back of the mouth (the pharynx).
File results
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment
-
FOI/2022/0540 - Electronic patient record
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm
-
FOI/2022/0576 - Medications within dermatology